print
Orencia (Abatacept) for rheumatoid arthritis (RA)
- Source agency:
- DMTP
- Date of Submission:
- 06/01/2010
- Date of Printing:
- 05/02/2012
- Technology name:
- Orencia (Abatacept) for rheumatoid arthritis (RA)
- Technology - type(s):
- Drug
- Patient indications:
- For the treatment of moderate - severe rheumatoid arthritis (RA) in adult patients who have insufficient response or intolerance to other anti-rheumatic drugs including at least one tumor-necrosis factor inhibitor.